145 related articles for article (PubMed ID: 22696691)
1. Nodular regenerative hyperplasia of the liver associated with didanosine persists for years even after its interruption.
Hofmaenner D; Kovari H; Weber A; Weishaupt D; Speck RF
BMJ Case Rep; 2011 May; 2011():. PubMed ID: 22696691
[TBL] [Abstract][Full Text] [Related]
2. [Non-cirrhotic portal hypertension due to didanosina. A rare case].
Gamero MT; Gallardo MS; Aguilar V; Bravo E; Guevara J; Mejia F
Rev Gastroenterol Peru; 2017; 37(1):87-90. PubMed ID: 28489843
[TBL] [Abstract][Full Text] [Related]
3. An unusual cause of oesophageal variceal bleeding in a Chinese human immunodeficiency virus-infected patient.
Hui YT; Lam WY; Lee MP; Lam TW; Li P
Hong Kong Med J; 2013 Feb; 19(1):77-9. PubMed ID: 23378360
[TBL] [Abstract][Full Text] [Related]
4. The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study.
Cotte L; Bénet T; Billioud C; Miailhes P; Scoazec JY; Ferry T; Brochier C; Boibieux A; Vanhems P; Chevallier M; Zoulim F
J Hepatol; 2011 Mar; 54(3):489-96. PubMed ID: 21056493
[TBL] [Abstract][Full Text] [Related]
5. [Regenerative nodular hyperplasia in HIV].
González RJ; Chaves E; Mullen E; Copello H
Acta Gastroenterol Latinoam; 2011 Dec; 41(4):320-3. PubMed ID: 22292230
[TBL] [Abstract][Full Text] [Related]
6. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.
Kovari H; Ledergerber B; Peter U; Flepp M; Jost J; Schmid P; Calmy A; Mueller NJ; Muellhaupt B; Weber R;
Clin Infect Dis; 2009 Aug; 49(4):626-35. PubMed ID: 19589079
[TBL] [Abstract][Full Text] [Related]
7. [Non-cirrhotic portal hypertension associated with didanosine: An unusual cause of gastrointestinal bleeding].
Gómez-Rubio J; Bárcena-Atalaya AB; Macías-García L; Lozano de León-Naranjo F
Med Clin (Barc); 2015 Jul; 145(1):45. PubMed ID: 25510631
[No Abstract] [Full Text] [Related]
8. Non-cirrhotic portal hypertension in HIV-infected individuals.
Scourfield A; Waters L; Holmes P; Panos G; Randell P; Jackson A; Mandalia S; Gazzard B; Nelson M
Int J STD AIDS; 2011 Jun; 22(6):324-8. PubMed ID: 21680667
[TBL] [Abstract][Full Text] [Related]
9. The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV.
Schiano TD; Uriel A; Dieterich DT; Fiel MI
Virchows Arch; 2011 Feb; 458(2):231-5. PubMed ID: 21057809
[TBL] [Abstract][Full Text] [Related]
10. Noncirrhotic portal hypertension and didanosine: a re-analysis.
Young J; Klein MB; Ledergerber B
Clin Infect Dis; 2011 Jan; 52(1):154-5. PubMed ID: 21148537
[No Abstract] [Full Text] [Related]
11. A woman with didanosine retinopathy and non-cirrhotic portal hypertension.
Pinto R; Lino S; Nogueira V; Fonseca A; Ornelas C
Int J STD AIDS; 2013 Mar; 24(3):247-9. PubMed ID: 24400350
[No Abstract] [Full Text] [Related]
12. Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension.
Schouten JN; Van der Ende ME; Koëter T; Rossing HH; Komuta M; Verheij J; van der Valk M; Hansen BE; Janssen HL
Aliment Pharmacol Ther; 2012 Nov; 36(9):875-85. PubMed ID: 22971050
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome.
Maida I; Garcia-Gasco P; Sotgiu G; Rios MJ; Vispo ME; Martin-Carbonero L; Barreiro P; Mura MS; Babudieri S; Albertos S; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):103-7. PubMed ID: 18389904
[TBL] [Abstract][Full Text] [Related]
14. Noncirrhotic portal hypertension: another cause of liver disease in HIV patients.
Mendizabal M; Craviotto S; Chen T; Silva MO; Reddy KR
Ann Hepatol; 2009; 8(4):390-5. PubMed ID: 20009143
[TBL] [Abstract][Full Text] [Related]
15. Nodular regenerative hyperplasia: a new serious antiretroviral drugs side effect?
Sandrine PF; Sylvie A; André E; Abdoulaye D; Bernard L; André C
AIDS; 2007 Jul; 21(11):1498-9. PubMed ID: 17589205
[No Abstract] [Full Text] [Related]
16. Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia.
Carr A; Morey A; Mallon P; Williams D; Thorburn DR
Lancet; 2001 May; 357(9266):1412-4. PubMed ID: 11356442
[TBL] [Abstract][Full Text] [Related]
17. Noncirrhotic portal hypertension associated with didanosine: a case report and literature review.
Chang HM; Tsai HC; Lee SS; Wann SR; Chen YS
Jpn J Infect Dis; 2012; 65(1):61-5. PubMed ID: 22274160
[TBL] [Abstract][Full Text] [Related]
18. Response to Mallet et al., 'Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients'.
Garvey LJ; Thomson EC; Lloyd J; Cooke GS; Goldin RD; Main J
AIDS; 2007 Jul; 21(11):1494-5. PubMed ID: 17589202
[No Abstract] [Full Text] [Related]
19. Upper gastrointestinal bleeding may unmask didanosine-associated portal hepatopathy in HIV/HCV co-infected patients.
Vispo E; Maida I; Barreiro P; Moreno V; Soriano V
HIV Clin Trials; 2008; 9(6):440-4. PubMed ID: 19203910
[TBL] [Abstract][Full Text] [Related]
20. Severe liver disease associated with prolonged exposure to antiretroviral drugs.
Maida I; Núñez M; Ríos MJ; Martín-Carbonero L; Sotgiu G; Toro C; Rivas P; Barreiro P; Mura MS; Babudieri S; Garcia-Samaniego J; González-Lahoz J; Soriano V
J Acquir Immune Defic Syndr; 2006 Jun; 42(2):177-82. PubMed ID: 16688096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
